Ke Wang

8PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Intensive careVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 02, 2026
Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2.

Ke Wang, Peng Lin, Ruo Chen

|Jan 10, 2025
Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non-small-cell lung cancer.

Yong Zhang, Xiang-Xiang Chen, Ruo Chen

|Jun 14, 2024
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis.

Ke Wang, Xiaohong Chen, Peng Lin

|Feb 24, 2024
Dclre1c-Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research.

Yixiao Bin, Sanhua Wei, Ruo Chen

|Jan 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial.

Huijie Bian, Liang Chen, Zhao-Hui Zheng

|Jan 21, 2023
Immunological and metabolic characteristics of the Omicron variants infection.

Jiejie Geng, Xu Yang, Kun Wang

Pageof 2

Frequent Collaborators

4 joint publications

Huijie Bian

3 joint publications

Chuan Qin

2 joint publications

Youchun Wang

1 joint publications

Jing Yuan